Scrip Asks...What Is The Current Trend For Open Innovation In Asia?
Executive Summary
Open Innovation and global partnering are becoming one of the most frequent themes of bio conferences in South Korea and elsewhere. Scrip talked to global experts at the recent Bio Korea 2018 meeting about their views on the current climate and trends for open innovation in Asia, as well as some challenges and benefits in pursuing open innovation approaches with Asian companies.
You may also be interested in...
GC-Yuhan Orphan Alliance Signals Changing Korean Views On Open Innovation
In what appears to be the first open innovation-based partnership between leading South Korean pharma firms, GC Pharma and Yuhan have agreed to conduct joint early research on orphan drugs, capitalizing on each others' strengths. The move may herald a shift in domestic companies' views on such collaboration and a possible increase in similar tie-ups, amid their ongoing efforts to pursue innovation.
J&J Hones In On Research Alliances, Human Capital As It Expands Singapore Hub
J&J is building its broad presence in Asia Pacific with the opening of an expanded regional hub in Singapore that will pursue R&D partnership, "design-led" health solutions, and human resource development.
How Intract Is Helping Shape Microbiome-Based Therapies
Bill Lindsay, CEO of University College London spin-out Intract Pharma, tells Scrip in an interview how the firm’s novel technologies are expected to play a key role in the effective delivery of microbiome-based therapies.